Jeffrey M. Leiden
2014 - Vertex Pharmaceuticals
|Non-Equity Incentive Plan||$2,970,000|
Leiden received $19.9M in stock awards, accounting for 54.27% of the total pay in 2014.
Leiden also received $3M in non-equity incentive plan, $12.7M in option awards, $1.1M in salary and $12.9K in other compensation.
In 2014, Jeffrey M. Leiden's compensation ranked 34th out of 13,032 executives tracked by ExecPay. In other words, Leiden earned more than 99.7% of executives.
Chemicals And Allied Products
We found four more compensation records of executives who worked with Jeffrey M. Leiden at Vertex Pharmaceuticals in 2014.